CARDIOVASCULAR MEDICINE

ß Blockers in older persons with heart failure: tolerability and impact on quality of life

A J Baxter¹, A Spensley¹, A Hildreth², G Karimova², J E O’Connell¹, C S Gray¹

¹ Department of Geriatric Medicine, Sunderland Royal Hospital, University of Newcastle upon Tyne, Sunderland, UK
² Department of Statistics, University of Newcastle upon Tyne

Correspondence to:
Correspondence to:
Dr AJ Baxter, Department of Geriatric Medicine, University of Newcastle upon Tyne, Sunderland Royal Hospital, Kayll Road, Sunderland SR4 7TP, UK;
john.baxter{at}chs.northy.nhs.uk

Objective: To determine tolerability and symptom changes associated with the introduction of bisoprolol treatment in older patients with heart failure.

Design: Prospective observational cohort study.

Setting: Geriatric medicine outpatient department of a university hospital.

Patients: 51 patients (mean age 78 years, range 70–89 years) with stable symptomatic heart failure caused by left ventricular systolic dysfunction.

Interventions: Bisoprolol tablets, 1.25–10.0 mg.

Main outcome measures: Tolerability; changes in symptoms and exercise tolerance.

Results: 69% of patients tolerated bisoprolol. Mean tolerated dose was 7.6 mg. There was no change in symptoms or exercise capacity in those who tolerated bisoprolol. Perceived health status and symptoms of anxiety and depression improved during the titration period.

Conclusions: The rate of withdrawal from bisoprolol treatment in older patients with congestive heart failure was twice that previously reported in younger patients. The mean tolerated dose was similar to that found in trials reporting clinical efficacy. There was no evidence of a negative impact on symptoms or exercise capacity in patients who tolerated bisoprolol.

Keywords: heart failure; old age; bisoprolol; ß blocker

Abbreviations: ACE, angiotensin converting enzyme; CIBIS-II, cardiac insufficiency bisoprolol study II; CMSS, co-morbidity symptom scale; GHQ, general health questionnaire; HAD, hospital anxiety and depression scale; MERIT-HF, metoprolol CR/XL randomised intervention trial in congestive heart failure; NYHA, New York Heart Association

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• Gustafsson, F., Schou, M., Videbaek, L., Nielsen, T., Ulriksen, H., Markenvard, J., Svendsen, T. L., Ryde, H., Vigholt, E., Hildebrandt, P., on behalf of the Danish Heart Failure Clinics Netw, (2007). Treatment with beta-blockers in nurse-led heart failure clinics: Titration efficacy and predictors of failure. Eur J Heart Fail 9: 910-916 [Abstract] [Full Text]  
• Opasich, C., Boccanelli, A., Cafiero, M., Cirrincione, V., Del Sindaco, D., Lenarda, A. D., Luzio, S. D., Faggiano, P., Frigerio, M., Lucci, D., Porcu, M., Pulignano, G., Scherillo, M., Tavazzi, L., Maggioni, A. P., BRING-UP 2 Investigators, (2006). Programme to improve the use of beta-blockers for heart failure in the elderly and in those with severe symptoms: Results of the BRING-UP 2 Study. Eur J Heart Fail 8: 649-657 [Abstract] [Full Text]  
• Witham, M. D., Argo, I. S., Johnston, D. W., Struthers, A. D., McMurdo, M. E.T. (2006). Predictors of exercise capacity and everyday activity in older heart failure patients. Eur J Heart Fail 8: 203-207 [Abstract] [Full Text]  
• Schuchert, A., On behalf of the BISEX Investigators (Appendix A), (2005). Effects of bisoprolol treatment for chronic heart failure initiated and followed up by primary care physicians. Eur J Heart Fail 7: 604-611 [Abstract] [Full Text]  
• Flather, M. D., Shibata, M. C., Coats, A. J.S., Van Veldhuisen, D. J., Parkhomenko, A., Borbola, J., Cohen-Solal, A., Dumitrascu, D., Ferrari, R., Lechat, P., Soler-Soler, J., Tavazzi, L., Spinarova, L., Toman, J., Bohm, M., Anker, S. D., Thompson, S. G., Poole-Wilson, P. A., on behalf of the SENIORS Investigators, (2005). Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS). Eur Heart J 26: 215-225 [Abstract] [Full Text]  
• Willenheimer, R., Erdmann, E., Follath, F., Krum, H., Ponikowski, P., Silke, B., van Veldhuisen, D. J., van de Ven, L., Verkenne, P., Lechat, P., on behalf of the CIBIS-III investigators, (2004). Comparison of treatment initiation with bisoprolol vs. enalapril in chronic heart failure patients: rationale and design of CIBIS-III. Eur J Heart Fail 6: 493-500 [Abstract] [Full Text]